Literature DB >> 2543635

Relationship between neutrophil-mediated oxidative injury during acute experimental pyelonephritis and chronic renal scarring.

P R Meylan1, M Markert, J Bille, M P Glauser.   

Abstract

Previous experiments with rats have suggested that pyelonephritic scarring after acute ascending Escherichia coli pyelonephritis partly results from excessive polymorphonuclear leukocyte (PMN) infiltration and activation in the kidney parenchyma. We have studied the role of PMN oxidative metabolism in generating tissue injury during acute pyelonephritis. Rats with acute pyelonephritis were treated with dapsone (25 mg/kg twice daily for 3 days), a compound known to prevent PMN oxidant damage. In vitro, levels of dapsone easily achieved in vivo inhibited myeloperoxidase (MPO)-mediated reactions involving the oxidation of halides to reactive cytotoxic hypohalites (such as MPO-mediated iodination and luminol-enhanced chemiluminescence). In contrast, dapsone had no effect on superoxide production, lysosomal enzyme release, or bacterial killing by activated PMN. In vivo, dapsone treatment had no significant effect on acute pyelonephritis with respect to (i) bacterial counts, (ii) inflammatory swelling, and (iii) PMN infiltration. However, dapsone-treated animals sacrificed 2 months after acute pyelonephritis had a 65% reduction of renal scars when compared with controls. Since dapsone had no antibacterial effect, this protection is compatible with the hypothesis that dapsone prevented oxidant-generated tissue injury due to the extracellular release of the MPO system by activated PMN during acute suppurative pyelonephritis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2543635      PMCID: PMC313860          DOI: 10.1128/iai.57.7.2196-2202.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Sulfone therapy of leprosy.

Authors:  Y T CHANG; R R WOLCOTT; J A DOULL
Journal:  Med Clin North Am       Date:  1954-03       Impact factor: 5.456

2.  The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone. A possible mechanism in the treatment of dermatitis herpetiformis.

Authors:  O Stendahl; L Molin; C Dahlgren
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

3.  Myeloperoxidase-mediated platelet release reaction.

Authors:  R A Clark; S J Klebanoff
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

4.  Sulfones and sulfonamides in dermatology today.

Authors:  P G Lang
Journal:  J Am Acad Dermatol       Date:  1979-12       Impact factor: 11.527

Review 5.  Release of inflammatory mediators from stimulated neutrophils.

Authors:  G Weissmann; J E Smolen; H M Korchak
Journal:  N Engl J Med       Date:  1980-07-03       Impact factor: 91.245

6.  The effect of antimicrobial agents on leukocyte chemotaxis.

Authors:  N B Esterly; N L Furey; L E Flanagan
Journal:  J Invest Dermatol       Date:  1978-01       Impact factor: 8.551

7.  Immunology of pyelonephritis in the primate model: live versus heat-killed bacteria.

Authors:  J A Roberts; G J Domingue; L N Martin; J C Kim
Journal:  Kidney Int       Date:  1981-02       Impact factor: 10.612

8.  Pyelonephritis: the relationship between infection, renal scarring, and antimicrobial therapy.

Authors:  T Miller; S Phillips
Journal:  Kidney Int       Date:  1981-05       Impact factor: 10.612

9.  In vitro and in vivo effects of dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy.

Authors:  R Anderson; E M Gatner; C E van Rensburg; G Grabow; F M Imkamp; S K Kok; A J van Rensburg
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

10.  Effects of dapsone on passive Arthus reaction and chemotaxis and phagocytosis of polymorphonuclear leukocytes.

Authors:  T Ruzicka; A Bauer; S Glück; M Born
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

View more
  9 in total

1.  A Common Genetic Variant in TLR1 Enhances Human Neutrophil Priming and Impacts Length of Intensive Care Stay in Pediatric Sepsis.

Authors:  Laura C Whitmore; Jessica S Hook; Amanda R Philiph; Brieanna M Hilkin; Xinyu Bing; Chul Ahn; Hector R Wong; Polly J Ferguson; Jessica G Moreland
Journal:  J Immunol       Date:  2016-01-04       Impact factor: 5.422

2.  Corticosteroids to prevent kidney scarring in children with a febrile urinary tract infection: a randomized trial.

Authors:  Nader Shaikh; Timothy R Shope; Alejandro Hoberman; Gysella B Muniz; Sonika Bhatnagar; Andrew Nowalk; Robert W Hickey; Marian G Michaels; Diana Kearney; Howard E Rockette; Martin Charron; Ruth Lim; Massoud Majd; Eglal Shalaby-Rana; Marcia Kurs-Lasky; Daniel M Cohen; Ellen R Wald; Greg Lockhart; Hans G Pohl; Judith M Martin
Journal:  Pediatr Nephrol       Date:  2020-06-15       Impact factor: 3.714

3.  Evaluation of acute pyelonephritis with DMSA scans in children presenting after the age of 5 years.

Authors:  Neamatollah Ataei; Abbas Madani; Reza Habibi; Mosa Khorasani
Journal:  Pediatr Nephrol       Date:  2005-08-05       Impact factor: 3.714

4.  Evaluation of tumour necrosis factor-alpha and interleukin-1beta in an experimental pyelonephritis model induced with planktonic and biofilms cells of Pseudomonas aeruginosa.

Authors:  Rahul Mittal; Saroj Sharma; Sanjay Chhibber; Kusum Harjai
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

5.  The effects of methylene blue on renal scarring due to pyelonephritis in rats.

Authors:  Burhan Aksu; Mustafa Inan; Mehmet Kanter; Fulya Oz Puyan; Hafize Uzun; Gulay Durmus-Altun; Saban Gurcan; Seval Aydin; Suleyman Ayvaz; Mehmet Pul
Journal:  Pediatr Nephrol       Date:  2007-03-28       Impact factor: 3.714

6.  Evaluation of Effectiveness of Vitamins C and E on Prevention of Renal Scar due to Pyelonephritis in Rat.

Authors:  Fatemeh Emamghorashi; Seyed Mohamad Owji; Mohammad Motamedifar
Journal:  Adv Urol       Date:  2010-12-12

7.  Neutrophil-Macrophage Imbalance Drives the Development of Renal Scarring during Experimental Pyelonephritis.

Authors:  Juan de Dios Ruiz-Rosado; Frank Robledo-Avila; Hanna Cortado; Javier Rangel-Moreno; Sheryl S Justice; Ching Yang; John David Spencer; Brian Becknell; Santiago Partida-Sanchez
Journal:  J Am Soc Nephrol       Date:  2020-11-04       Impact factor: 14.978

8.  Could pyelonephritic scarring be prevented by anti-inflammatory treatment? An experimental model of acute pyelonephritis.

Authors:  Elif Bahat Özdoğan; Tuğba Özdemir; Seçil Arslansoyu Çamlar; Mustafa Imamoğlu; Ümit Cobanoğlu; Bircan Sönmez; İlknur Tosun; Ismail Doğan
Journal:  Biomed Res Int       Date:  2014-07-03       Impact factor: 3.411

9.  Oral steroids for reducing kidney scarring in young children with febrile urinary tract infections: the contribution of Bayesian analysis to a randomized trial not reaching its intended sample size.

Authors:  Liviana Da Dalt; Silvia Bressan; Floriana Scozzola; Enrico Vidal; Monia Gennari; Claudio La Scola; Mauro Anselmi; Elisabetta Miorin; Pietro Zucchetta; Danila Azzolina; Dario Gregori; Giovanni Montini
Journal:  Pediatr Nephrol       Date:  2021-05-25       Impact factor: 3.714

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.